Takara Bio (STU:TF2) Research & Development: €38.7 Mil (TTM As of Mar. 2026)


STU:TF2 Takara Bio Inc STU:TF2
71 GF Score
Price €6.00
GF Value €4.49
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Takara Bio Research & Development?

Takara Bio STU:TF2 71 Research & Development is €38.7 Mil as of Mar. 2026. GuruFocus rates STU:TF2 with a GF Score™ of 71/100 and a GF Value™ of €4.49 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Takara Bio's Research & Development for the three months ended in Mar. 2026 was €9.4 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €38.7 Mil.

Takara Bio  (STU:TF2) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Takara Bio Research & Development Related Terms

Takara Bio Research & Development Historical Data

* Premium members only.

The historical data trend for Takara Bio's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Takara Bio Research & Development Chart

Takara Bio Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46.78 59.92 51.12 42.80 37.10

Takara Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.04 10.72 9.85 8.73 9.35
STU:TF2
71GF Score
Takara Bio Inc STU:TF2
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Takara Bio Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €38.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €38.7 Mil mean?
Takara Bio (STU:TF2) has a Research & Development of €38.7 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Takara Bio and its competitors.
Is Takara Bio's Research & Development too high?
Takara Bio's current Research & Development is €38.7 Mil. Overall, Takara Bio has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Takara Bio's Research & Development compare to VRTX and REGN?
Takara Bio's Research & Development of €38.7 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Takara Bio and its competitors. Takara Bio's current Research & Development is €38.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Takara Bio stock overvalued right now?
Based on GuruFocus' analysis, Takara Bio (STU:TF2) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.49, compared to a current price of €6.00 — trading 33.6% above its estimated fair value. The current Research & Development is €38.7 Mil. Takara Bio's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Takara Bio (STU:TF2), the current Research & Development is €38.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Takara Bio (STU:TF2) Overvalued in 2026?

Based on GuruFocus' analysis, Takara Bio stock appears to be overvalued. The current stock price of €6.00 is trading 33.6% above its estimated GF Value™ of €4.49. GuruFocus considers Takara Bio to be Significantly Overvalued.

Key valuation signals for STU:TF2:

  • Research & Development: €38.7 Mil
  • GF Value™: €4.49 vs. price of €6.00 (33.6% above fair value)
  • GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the STU:TF2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Takara Bio Business Description

Other Exchanges 4974:JapanTF2:Germany
Address Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058
Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.
71GF Score

Get the complete analysis for STU:TF2

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.00
Price
€4.49
GF Value